Barrett’s esophagus is a precursor to esophageal cancer, with early detection improving survival rates significantly. Definitions of Barrett’s esophagus vary, impacting esophageal cancer detection ...

Patients presenting to the emergency department with esophageal food impaction commonly do not receive an esophageal biopsy to diagnose EoE, representing a missed diagnostic opportunity.

As a result of the firm's financial results, Castle Bio raised its full-year 2025 revenue guidance to between $327 and $335 million from a range of $310 to $320 million.

Acid reflux can feel like your heart or chest is burning. If you've ever experienced acid reflux, you may have wondered if it ...

The final, formatted version of the article will be published soon. Objective:We developed interpretable machine learning(ML) models to predict the overall survival(OS) of esophageal cancer patients.

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer ...

Innovations like endoscopic imaging, AI-enhanced tools, and minimally invasive therapies are reshaping patient care. Despite challenges like public awareness gaps and cost barriers, strategic ...

Castle Biosciences (CSTL) announced new data demonstrating that its TissueCypher Barrett’s Esophagus test can provide risk insights beyond ...

Research on TissueCypher by Horvath et al. honored with a Presidential Poster Award from the ACG Abstract Selection Committee ...

FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that ...

An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect ...

Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating PotentialUNIONDALE, NY, ...